Omicron-targeting COVID boosters expected this week, but experts are worried there may be low uptake
admin The Food and Drug Administration is expected to authorize new COVID-19 booster shots this week…
Read MoreHealth Care
Report finds Americans with long COVID losing billions in wages, as Moderna sues Pfizer and BioNTech over mRNA patents
Some 16 million Americans of working age have long-term COVID and as many as 4…
Read MoreStudy finds Pfizer’s antiviral has little or even zero benefit for younger adults, and WHO says BA.5 omicron subvariant accounted for 74% of cases in latest week
Pfizer’s COVID antiviral Paxlovid appears to have little or no benefit for younger adults, although…
Read MoreOmicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization
Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day,…
Read MoreOmicron-specific boosters could be rolled out after Labor Day: report
Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor Day,…
Read MorePfizer and BioNTech say data show COVID vaccine has more than 70% efficacy in small children, with cases now rising in just 7 states
Pfizer and German partner BioNTech on Tuesday offered updated COVID vaccine data supporting efficacy in…
Read MoreJill Biden leaves isolation after twice testing negative, and Novavax vaccine is now allowed for U.S. teens
First lady Jill Biden left isolation on Sunday, after testing negative for COVID twice and…
Read MoreLarge-scale study finds COVID patients at higher risk of brain fog and psychosis after two years compared with other respiratory illnesses
People who have had COVID-19 are facing a higher risk of neurological and psychiatric conditions…
Read MoreTrial finds 100-year-old tuberculosis vaccine offers protection against COVID to high-risk patients and may help with other infectious diseases
Data from a trial seeking to determine whether multiple injections of a tuberculosis vaccine developed…
Read More
Only 5 stocks in the S&P 500 ended in positive territory after Powell’s hawkish inflation speech
It took only a 10-minute speech from Federal Reserve Chairman Jerome Powell on Friday to…
Read More